{"entity":{"type":"insider","cik":"0001272247","url":"/insider/0001272247","json_url":"/insider/0001272247.json","name":"HAUGHEY THOMAS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":94,"n_filings":11,"first":"2007-10-03","last":"2026-06-10","span_basis":"filed_date"},"name_variants":[{"name":"HAUGHEY THOMAS","source":"filing","n_filings":11,"first_seen":"2007-10-03","last_seen":"2026-06-10"}],"transactions":[{"id":5776927,"accession":"0001272247-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001272247-26-000004","line_url":"/filing/0001272247-26-000004#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":80.88,"price_display":"80.88","price_state":"stated","total_value":161760.0,"total_display":"161,760.00","total_whole":"161,760","shares_owned_after":38878.0,"shares_owned_after_display":"38,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-08","filed_date":"2026-06-10","scope":"insider"},{"id":5000876,"accession":"0001272247-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001272247-25-000005","line_url":"/filing/0001272247-25-000005#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19341.0,"shares_display":"19,341","price_per_share":85.93,"price_display":"85.93","price_state":"stated","total_value":1661972.13,"total_display":"1,661,972.13","total_whole":"1,661,972","shares_owned_after":36521.0,"shares_owned_after_display":"36,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":4446815,"accession":"0001415889-21-005743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005743","line_url":"/filing/0001415889-21-005743#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":39.38,"price_display":"39.38","price_state":"stated","total_value":98450.0,"total_display":"98,450.00","total_whole":"98,450","shares_owned_after":30202.0,"shares_owned_after_display":"30,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider"},{"id":2557159,"accession":"0001104659-20-029791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-029791","line_url":"/filing/0001104659-20-029791#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":45.05,"price_display":"45.05","price_state":"stated","total_value":135150.0,"total_display":"135,150.00","total_whole":"135,150","shares_owned_after":11291.0,"shares_owned_after_display":"11,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-04","filed_date":"2020-03-05","scope":"insider"},{"id":2557155,"accession":"0001104659-20-029791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-029791","line_url":"/filing/0001104659-20-029791#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":45.18,"price_display":"45.18","price_state":"stated","total_value":90360.0,"total_display":"90,360.00","total_whole":"90,360","shares_owned_after":8291.0,"shares_owned_after_display":"8,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-05","scope":"insider"},{"id":8324175,"accession":"0001144204-19-026615","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-026615","line_url":"/filing/0001144204-19-026615#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":69.296,"price_display":"69.30","price_state":"stated","total_value":173240.0,"total_display":"173,240.00","total_whole":"173,240","shares_owned_after":6291.0,"shares_owned_after_display":"6,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-15","filed_date":"2019-05-15","scope":"insider"},{"id":9127146,"accession":"0000878088-11-000048","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0000878088-11-000048","line_url":"/filing/0000878088-11-000048","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26800.0,"shares_display":"26,800","price_per_share":35.54951828358209,"price_display":"35.55","price_state":"stated","total_value":952727.09,"total_display":"952,727.09","total_whole":"952,727","shares_owned_after":81097.0,"shares_owned_after_display":"81,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-10","filed_date":"2011-05-11","scope":"insider","n_lines":24},{"id":9087794,"accession":"0000878088-11-000047","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-26","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46961.0,"shares_display":"46,961","price_per_share":35.2,"price_display":"35.20","price_state":"stated","total_value":1653027.2,"total_display":"1,653,027.20","total_whole":"1,653,027","shares_owned_after":126400.0,"shares_owned_after_display":"126,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087793,"accession":"0000878088-11-000047","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-25","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26313.0,"shares_display":"26,313","price_per_share":34.45,"price_display":"34.45","price_state":"stated","total_value":906482.85,"total_display":"906,482.85","total_whole":"906,483","shares_owned_after":90744.0,"shares_owned_after_display":"90,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087792,"accession":"0000878088-11-000047","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-24","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":35.19,"price_display":"35.19","price_state":"stated","total_value":200583.0,"total_display":"200,583.00","total_whole":"200,583","shares_owned_after":173361.0,"shares_owned_after_display":"173,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087791,"accession":"0000878088-11-000047","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-23","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4089.0,"shares_display":"4,089","price_per_share":34.46,"price_display":"34.46","price_state":"stated","total_value":140906.94,"total_display":"140,906.94","total_whole":"140,907","shares_owned_after":84755.0,"shares_owned_after_display":"84,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087790,"accession":"0000878088-11-000047","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-22","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3155.0,"shares_display":"3,155","price_per_share":35.23,"price_display":"35.23","price_state":"stated","total_value":111150.65,"total_display":"111,150.65","total_whole":"111,151","shares_owned_after":119997.0,"shares_owned_after_display":"119,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087789,"accession":"0000878088-11-000047","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-21","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3048.0,"shares_display":"3,048","price_per_share":35.22,"price_display":"35.22","price_state":"stated","total_value":107350.56,"total_display":"107,350.56","total_whole":"107,351","shares_owned_after":123352.0,"shares_owned_after_display":"123,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087788,"accession":"0000878088-11-000047","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-20","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":34.49,"price_display":"34.49","price_state":"stated","total_value":89674.0,"total_display":"89,674.00","total_whole":"89,674","shares_owned_after":81455.0,"shares_owned_after_display":"81,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087787,"accession":"0000878088-11-000047","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-19","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2587.0,"shares_display":"2,587","price_per_share":35.24,"price_display":"35.24","price_state":"stated","total_value":91165.88,"total_display":"91,165.88","total_whole":"91,166","shares_owned_after":117410.0,"shares_owned_after_display":"117,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087786,"accession":"0000878088-11-000047","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-18","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2187.0,"shares_display":"2,187","price_per_share":35.15,"price_display":"35.15","price_state":"stated","total_value":76873.05,"total_display":"76,873.05","total_whole":"76,873","shares_owned_after":179261.0,"shares_owned_after_display":"179,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087785,"accession":"0000878088-11-000047","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-17","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":34.455,"price_display":"34.46","price_state":"stated","total_value":65464.5,"total_display":"65,464.50","total_whole":"65,465","shares_owned_after":88844.0,"shares_owned_after_display":"88,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087784,"accession":"0000878088-11-000047","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-16","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":35.08,"price_display":"35.08","price_state":"stated","total_value":56128.0,"total_display":"56,128.00","total_whole":"56,128","shares_owned_after":184048.0,"shares_owned_after_display":"184,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087783,"accession":"0000878088-11-000047","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-15","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":35.12,"price_display":"35.12","price_state":"stated","total_value":52680.0,"total_display":"52,680.00","total_whole":"52,680","shares_owned_after":181648.0,"shares_owned_after_display":"181,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087782,"accession":"0000878088-11-000047","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-14","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":34.55,"price_display":"34.55","price_state":"stated","total_value":44915.0,"total_display":"44,915.00","total_whole":"44,915","shares_owned_after":79355.0,"shares_owned_after_display":"79,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087781,"accession":"0000878088-11-000047","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-13","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":34.5,"price_display":"34.50","price_state":"stated","total_value":24150.0,"total_display":"24,150.00","total_whole":"24,150","shares_owned_after":80755.0,"shares_owned_after_display":"80,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087780,"accession":"0000878088-11-000047","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-12","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":35.1,"price_display":"35.10","price_state":"stated","total_value":21060.0,"total_display":"21,060.00","total_whole":"21,060","shares_owned_after":183448.0,"shares_owned_after_display":"183,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087779,"accession":"0000878088-11-000047","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-11","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":34.48,"price_display":"34.48","price_state":"stated","total_value":13792.0,"total_display":"13,792.00","total_whole":"13,792","shares_owned_after":84055.0,"shares_owned_after_display":"84,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087778,"accession":"0000878088-11-000047","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-10","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":353.0,"shares_display":"353","price_per_share":35.25,"price_display":"35.25","price_state":"stated","total_value":12443.25,"total_display":"12,443.25","total_whole":"12,443","shares_owned_after":117057.0,"shares_owned_after_display":"117,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087777,"accession":"0000878088-11-000047","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-9","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":35.11,"price_display":"35.11","price_state":"stated","total_value":10533.0,"total_display":"10,533.00","total_whole":"10,533","shares_owned_after":183148.0,"shares_owned_after_display":"183,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087776,"accession":"0000878088-11-000047","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-8","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":34.56,"price_display":"34.56","price_state":"stated","total_value":10368.0,"total_display":"10,368.00","total_whole":"10,368","shares_owned_after":79055.0,"shares_owned_after_display":"79,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"},{"id":9087775,"accession":"0000878088-11-000047","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000878088-11-000047","line_url":"/filing/0000878088-11-000047#line-7","is_derivative":false,"issuer_cik":"0000878088","issuer_name":"PAR PHARMACEUTICAL COMPANIES, INC.","issuer_ticker":"PRX","issuer_name_source":null,"issuer_url":"/issuer/0000878088","owner_cik":"0001272247","owner_name":"HAUGHEY THOMAS","owner_display_name":"HAUGHEY THOMAS","owner_url":"/insider/0001272247","role":"Officer (EVP, CAO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CAO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CAO, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":35.225,"price_display":"35.22","price_state":"stated","total_value":7045.0,"total_display":"7,045.00","total_whole":"7,045","shares_owned_after":123152.0,"shares_owned_after_display":"123,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-09","filed_date":"2011-05-11","scope":"insider"}],"collapsed":true,"next_cursor":"2011-05-09|9087775","ledger_fault":false,"count":{"value":94,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":85,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":94},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001023024","name":"ANI PHARMACEUTICALS INC","url":"/issuer/0001023024","role":"Director","n_filings":5,"first_seen":"2019-05-15","last_seen":"2026-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000878088","name":"PAR PHARMACEUTICAL COMPANIES, INC.","url":"/issuer/0000878088","role":"Officer (EVP, CAO, General Counsel)","n_filings":6,"first_seen":"2007-10-03","last_seen":"2011-05-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001272247","retrieved_at":"2026-08-22T09:15:17+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}